Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Drews

Showing results (31-40 of 179) with videos related to

Pageof 18
Sort By:
Vox Sanguinis|March 14, 2024
Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID-19 restriction in March 2020Steven J Drews, Carmen Charlton, Sheila F O'Brien, et al.
Canadian Respiratory Journal|July 10, 2010
The Ontario universal typing of tuberculosis (OUT-TB) surveillance program--what it means to youShelly Bolotin, David C Alexander, Jennifer L Guthrie, et al.
Viruses|November 11, 2022
SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of OmicronSheila F O'Brien, Niamh Caffrey, Qi-Long Yi, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|April 3, 2024
SARS-CoV-2 seroprevalence in Nova Scotia blood donorsSheila F O'Brien, Shelley L Deeks, Todd Hatchette, et al.
Microbiology Spectrum|April 12, 2022
Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine EraCassandra N Reedman, Steven J Drews, Qi-Long Yi, et al.
Vox Sanguinis|June 1, 2026
Chagas disease in Canadian blood donors: 15 years of selective testingSheila F O'Brien, Mindy Goldman, Antoine Lewin, et al.
Transfusion|August 17, 2020
Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature reviewJean-François Leblanc, Marc Germain, Gilles Delage, et al.
Transfusion|October 4, 2022
How do we decide how representative our donors are for public health surveillance?Sheila F O'Brien, Steven J Drews, Antoine Lewin, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|November 18, 2008
Decentralized molecular diagnostic testing plan for pandemic influenza in the Ontario Public Health Laboratory systemSteven J Drews, Anna Majury, Frances Jamieson, et al.
Pharmaceutics|October 27, 2022
Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles ExpressionKhushwant S Bhullar, Manal A Nael, Khaled M Elokely, et al.
Pageof 18

Showing results (31-40 of 179) with videos related to

Sort By:
Pageof 18
Vox Sanguinis|March 14, 2024
Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID-19 restriction in March 2020Steven J Drews, Carmen Charlton, Sheila F O'Brien, et al.
Canadian Respiratory Journal|July 10, 2010
The Ontario universal typing of tuberculosis (OUT-TB) surveillance program--what it means to youShelly Bolotin, David C Alexander, Jennifer L Guthrie, et al.
Viruses|November 11, 2022
SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of OmicronSheila F O'Brien, Niamh Caffrey, Qi-Long Yi, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|April 3, 2024
SARS-CoV-2 seroprevalence in Nova Scotia blood donorsSheila F O'Brien, Shelley L Deeks, Todd Hatchette, et al.
Microbiology Spectrum|April 12, 2022
Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine EraCassandra N Reedman, Steven J Drews, Qi-Long Yi, et al.
Vox Sanguinis|June 1, 2026
Chagas disease in Canadian blood donors: 15 years of selective testingSheila F O'Brien, Mindy Goldman, Antoine Lewin, et al.
Transfusion|August 17, 2020
Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature reviewJean-François Leblanc, Marc Germain, Gilles Delage, et al.
Transfusion|October 4, 2022
How do we decide how representative our donors are for public health surveillance?Sheila F O'Brien, Steven J Drews, Antoine Lewin, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|November 18, 2008
Decentralized molecular diagnostic testing plan for pandemic influenza in the Ontario Public Health Laboratory systemSteven J Drews, Anna Majury, Frances Jamieson, et al.
Pharmaceutics|October 27, 2022
Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles ExpressionKhushwant S Bhullar, Manal A Nael, Khaled M Elokely, et al.
Pageof 18